Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Researchers at the Salk Institute have identified a missing molecule, pleiotrophin, as a possible key to repairing faulty brain circuits in Down syndrome. New research indicates that faulty brain circ ...

A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...

Electra Therapeutics has garnered the funds it needs to complete a pivotal trial of its lead drug, angling to become the ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

The hyperfine structure of radium monofluoride has been measured by researchers in the US and elsewhere with such precision ...

Critters consuming species that contain deadly toxins have evolved a suite of clever strategies to keep out of harm's way.

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...